{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:48Z","timestamp":1786980288671,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Invasive lobular carcinoma (ILC) represents the second most common type of invasive breast cancer (BC). Although ILC generally have good prognostic properties (positive estrogen receptor, ER, low tumor grade), they are generally diagnosed at a\u00a0more advanced stage. The data on the axillary lymph node status in ILC compared to invasive ductal carcinoma (IDC) are considered controversial. Therefore, the aim of this study was to compare the pathological node stage (pN) between ILC and IDC in an Austria-wide register.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data of the Clinical Tumor Register (Klinisches TumorRegister, KTR) of the Austrian Association for Gynecological Oncology (AGO) were retrospectively analyzed. Patients with primary early BC, invasive lobular or ductal, diagnosed between January 2014 and December 2018, and primary surgery were included. A\u00a0total of 2127 tumors were evaluated and compared in 2\u00a0groups, ILC\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u2009303, IDC\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u20091824.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A\u00a0total of 2095\u00a0patients were analyzed in the study. In the multivariate analysis, pN2 and pN3 were observed significantly more frequently in ILC compared with IDC (odds ratio, OR 1.93; 95% confidence interval, CI 1.19\u20133.14;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u20090.008 and OR 3.22; 95% CI: 1.47\u20137.03;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u20090.003; respectively). Other factors associated with ILC were tumor grades\u00a02 and\u00a03, positive ER, and pathological tumor stage (pT) 2 and pT3. In contrast, concomitant ductal carcinoma in situ, overexpression of the human epidermal growth factor receptor\u00a02 (HER2), and a\u00a0moderate and high proliferation rate (Ki67) were found less frequently in ILC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The data show an increased risk of extensive axillary lymph node metastasis (pN2\/3) in ILC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00508-023-02162-y","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T08:28:46Z","timestamp":1680510526000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Axillary lymph node status and invasive lobular breast cancer"],"prefix":"10.1007","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-6399","authenticated-orcid":false,"given":"Sabine","family":"Danzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"P\u00f6ckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerit","family":"Kronawetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gscheidlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Harrasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"M\u00fchlb\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Dirschlmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Reitsamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidemarie","family":"Uher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sch\u00f6nau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmgard","family":"Delmarko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"2162_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.soc.2017.07.005","volume":"27","author":"A Mamtani","year":"2018","unstructured":"Mamtani\u00a0A, King\u00a0TA. Lobular breast cancer: different disease, different algorithms? Surg Oncol Clin N Am. 2018;27:81\u201394.","journal-title":"Surg Oncol Clin N Am"},{"key":"2162_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.seminoncol.2019.03.002","volume":"46","author":"M Thomas","year":"2019","unstructured":"Thomas\u00a0M, Kelly\u00a0ED, Abraham\u00a0J, Kruse\u00a0M. Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease. Semin Oncol. 2019;46:121\u201332.","journal-title":"Semin Oncol"},{"key":"2162_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13058-015-0519-x","volume":"17","author":"AE McCart Reed","year":"2015","unstructured":"McCart Reed\u00a0AE, Kutasovic\u00a0JR, Lakhani\u00a0SR, Simpson\u00a0PT. Invasive lobular carcinoma of the breast: morphology, biomarkers and \u2019omics. Breast Cancer Res. 2015;17:12.","journal-title":"Breast Cancer Res"},{"key":"2162_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","volume":"37","author":"DJ Dabbs","year":"2013","unstructured":"Dabbs\u00a0DJ, Schnitt\u00a0SJ, Geyer\u00a0FC, Weigelt\u00a0B, Baehner\u00a0FL, Decker\u00a0T, et al. Lobular neoplasia of the breast revisited with emphasis on the role of E\u2011cadherin immunohistochemistry. Am J Surg Pathol. 2013;37:e1\u201311.","journal-title":"Am J Surg Pathol"},{"key":"2162_CR5","doi-asserted-by":"publisher","first-page":"591399","DOI":"10.3389\/fonc.2020.591399","volume":"10","author":"N Wilson","year":"2020","unstructured":"Wilson\u00a0N, Ironside\u00a0A, Diana\u00a0A, Oikonomidou\u00a0O. Lobular breast cancer: a review. Front Oncol. 2020;10:591399.","journal-title":"Front Oncol"},{"key":"2162_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10552-018-1121-1","volume":"30","author":"LA Williams","year":"2019","unstructured":"Williams\u00a0LA, Hoadley\u00a0KA, Nichols\u00a0HB, Geradts\u00a0J, Perou\u00a0CM, Love\u00a0MI, et\u00a0al. Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas. Cancer Causes Control. 2019;30:31\u20139.","journal-title":"Cancer Causes Control"},{"key":"2162_CR7","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1245\/s10434-010-0953-z","volume":"17","author":"N Wasif","year":"2010","unstructured":"Wasif\u00a0N, Maggard\u00a0MA, Ko\u00a0CY, Giuliano\u00a0AE. Invasive lobular vs. ductal breast cancer: a\u00a0stage-matched comparison of outcomes. Ann Surg Oncol. 2010;17:1862\u20139.","journal-title":"Ann Surg Oncol"},{"key":"2162_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/jclinpath-2011-200151","volume":"64","author":"B Fernandez","year":"2011","unstructured":"Fernandez\u00a0B, Paish\u00a0EC, Green\u00a0AR, Lee\u00a0AH, Macmillan\u00a0RD, Ellis\u00a0IO, et al. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast. J\u00a0Clin Pathol. 2011;64:995\u20131000.","journal-title":"J Clin Pathol"},{"key":"2162_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8","volume":"77","author":"X Sastre-Garau","year":"1996","unstructured":"Sastre-Garau\u00a0X, Jouve\u00a0M, Asselain\u00a0B, Vincent-Salomon\u00a0A, Beuzeboc\u00a0P, Dorval\u00a0T, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975\u00a0cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113\u201320.","journal-title":"Cancer"},{"key":"2162_CR10","doi-asserted-by":"publisher","first-page":"R149","DOI":"10.1186\/bcr767","volume":"6","author":"G Arpino","year":"2004","unstructured":"Arpino\u00a0G, Bardou\u00a0VJ, Clark\u00a0GM, Elledge\u00a0RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6:R149\u201356.","journal-title":"Breast Cancer Res"},{"key":"2162_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejca.2007.10.009","volume":"44","author":"EA Rakha","year":"2008","unstructured":"Rakha\u00a0EA, El-Sayed\u00a0ME, Powe\u00a0DG, Green\u00a0AR, Habashy\u00a0H, Grainge\u00a0MJ, et al. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer. 2008;44:73\u201383.","journal-title":"Eur J Cancer"},{"key":"2162_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1186\/1471-2407-10-664","volume":"10","author":"SY Jung","year":"2010","unstructured":"Jung\u00a0SY, Jeong\u00a0J, Shin\u00a0SH, Kwon\u00a0Y, Kim\u00a0EA, Ko\u00a0KL, et\u00a0al. The invasive lobular carcinoma as a\u00a0prototype luminal A breast cancer: a\u00a0retrospective cohort study. BMC Cancer. 2010;10:664.","journal-title":"BMC Cancer"},{"key":"2162_CR13","doi-asserted-by":"publisher","first-page":"e0182397","DOI":"10.1371\/journal.pone.0182397","volume":"12","author":"Z Chen","year":"2017","unstructured":"Chen\u00a0Z, Yang\u00a0J, Li\u00a0S, Lv\u00a0M, Shen\u00a0Y, Wang\u00a0B, et\u00a0al. Invasive lobular carcinoma of the breast: a special histological type compared with invasive ductal carcinoma. PLoS ONE. 2017;12:e182397.","journal-title":"PLoS ONE"},{"key":"2162_CR14","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1002\/onco.13734","volume":"26","author":"N Pramod","year":"2021","unstructured":"Pramod\u00a0N, Nigam\u00a0A, Basree\u00a0M, Mawalkar\u00a0R, Mehra\u00a0S, Shinde\u00a0N, et\u00a0al. Comprehensive review of molecular mechanisms and clinical features of invasive lobular cancer. Oncologist. 2021;26:e943\u2013e53.","journal-title":"Oncologist"},{"key":"2162_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40487-019-00105-0","volume":"8","author":"J Luveta","year":"2020","unstructured":"Luveta\u00a0J, Parks\u00a0RM, Heery\u00a0DM, Cheung\u00a0KL, Johnston\u00a0SJ. Invasive lobular breast cancer as a\u00a0distinct disease: implications for therapeutic strategy. Oncol Ther. 2020;8:1\u201311.","journal-title":"Oncol Ther"},{"key":"2162_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ejso.2013.02.007","volume":"39","author":"N Biglia","year":"2013","unstructured":"Biglia\u00a0N, Maggiorotto\u00a0F, Liberale\u00a0V, Bounous\u00a0VE, Sgro\u00a0LG, Pecchio\u00a0S, et al. Clinical-pathologic features, long term-outcome and surgical treatment in a\u00a0large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Surg Oncol. 2013;39:455\u201360.","journal-title":"Eur J Surg Oncol"},{"key":"2162_CR17","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","volume":"26","author":"BC Pestalozzi","year":"2008","unstructured":"Pestalozzi\u00a0BC, Zahrieh\u00a0D, Mallon\u00a0E, Gusterson\u00a0BA, Price\u00a0KN, Gelber\u00a0RD, et\u00a0al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J\u00a0Clin Oncol. 2008;26:3006\u201314.","journal-title":"J Clin Oncol"},{"key":"2162_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ejca.2003.08.007","volume":"40","author":"S Ferlicot","year":"2004","unstructured":"Ferlicot\u00a0S, Vincent-Salomon\u00a0A, Medioni\u00a0J, Genin\u00a0P, Rosty\u00a0C, Sigal-Zafrani\u00a0B, et al. Wide metastatic spreading in infiltrating lobular carcinoma of the breast. Eur J Cancer. 2004;40:336\u201341.","journal-title":"Eur J Cancer"},{"key":"2162_CR19","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher\u00a0B, Bauer\u00a0M, Wickerham\u00a0DL, Redmond\u00a0CK, Fisher\u00a0ER, Cruz\u00a0AB, et\u00a0al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983;52:1551\u20137.","journal-title":"Cancer"},{"key":"2162_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/ajcp\/88.2.123","volume":"88","author":"J Russo","year":"1987","unstructured":"Russo\u00a0J, Frederick\u00a0J, Ownby\u00a0HE, Fine\u00a0G, Hussain\u00a0M, Krickstein\u00a0HI, et\u00a0al. Predictors of recurrence and survival of patients with breast cancer. Am J Clin Pathol. 1987;88:123\u201331.","journal-title":"Am J Clin Pathol"},{"key":"2162_CR21","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/1097-0142(19930415)71:8<2507::AID-CNCR2820710813>3.0.CO;2-0","volume":"71","author":"ER Fisher","year":"1993","unstructured":"Fisher\u00a0ER, Anderson\u00a0S, Redmond\u00a0C, Fisher\u00a0B. Pathologic findings from the national surgical adjuvant breast project protocol B\u201106. 10-year pathologic and clinical prognostic discriminants. Cancer. 1993;71:2507\u201314.","journal-title":"Cancer"},{"key":"2162_CR22","doi-asserted-by":"publisher","first-page":"966","DOI":"10.5858\/2000-124-0966-PFIBC","volume":"124","author":"PL Fitzgibbons","year":"2000","unstructured":"Fitzgibbons\u00a0PL, Page\u00a0DL, Weaver\u00a0D, Thor\u00a0AD, Allred\u00a0DC, Clark\u00a0GM, et\u00a0al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:966\u201378.","journal-title":"Arch Pathol Lab Med"},{"key":"2162_CR23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1634\/theoncologist.2010-0044","volume":"15","author":"V Vinh-Hung","year":"2010","unstructured":"Vinh-Hung\u00a0V, Joseph\u00a0SA, Coutty\u00a0N, Ly\u00a0BH, Vlastos\u00a0G, Nguyen\u00a0NP. Age and axillary lymph node ratio in postmenopausal women with T1\u2013T2 node positive breast cancer. Oncologist. 2010;15:1050\u201362.","journal-title":"Oncologist"},{"key":"2162_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jamcollsurg.2011.04.024","volume":"213","author":"SC Schiffman","year":"2011","unstructured":"Schiffman\u00a0SC, McMasters\u00a0KM, Scoggins\u00a0CR, Martin\u00a0RC, Chagpar\u00a0AB. Lymph node ratio: a\u00a0proposed refinement of current axillary staging in breast cancer patients. J\u00a0Am Coll Surg. 2011;213:45\u201352. discussion \u20133.","journal-title":"J Am Coll Surg"},{"key":"2162_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10549-020-05885-y","volume":"184","author":"D Singh","year":"2020","unstructured":"Singh\u00a0D, Mandal\u00a0A. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients. Breast Cancer Res Treat. 2020;184:839\u201348.","journal-title":"Breast Cancer Res Treat"},{"key":"2162_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/ejso.2002.1423","volume":"29","author":"H Mersin","year":"2003","unstructured":"Mersin\u00a0H, Yildirim\u00a0E, Gulben\u00a0K, Berberoglu\u00a0U. Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol. 2003;29:390\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"2162_CR27","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B","volume":"73","author":"MJ Silverstein","year":"1994","unstructured":"Silverstein\u00a0MJ, Lewinsky\u00a0BS, Waisman\u00a0JR, Gierson\u00a0ED, Colburn\u00a0WJ, Senofsky\u00a0GM, et\u00a0al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994;73:1673\u20137.","journal-title":"Cancer"},{"key":"2162_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10549-020-05565-x","volume":"180","author":"SP Corona","year":"2020","unstructured":"Corona\u00a0SP, Bortul\u00a0M, Scomersi\u00a0S, Bigal\u00a0C, Bottin\u00a0C, Zanconati\u00a0F, et\u00a0al. Management of the axilla in breast cancer: outcome analysis in a\u00a0series of ductal versus lobular invasive cancers. Breast Cancer Res Treat. 2020;180:735\u201345.","journal-title":"Breast Cancer Res Treat"},{"key":"2162_CR29","doi-asserted-by":"publisher","first-page":"300060521101703","DOI":"10.1177\/03000605211017039","volume":"49","author":"S Danzinger","year":"2021","unstructured":"Danzinger\u00a0S, Hielscher\u00a0N, Izso\u00a0M, Metzler\u00a0J, Trinkl\u00a0C, Pfeifer\u00a0C, et\u00a0al. Invasive lobular carcinoma: clinicopathological features and subtypes. J\u00a0Int Med Res. 2021;49:3000605211017039.","journal-title":"J Int Med Res"},{"key":"2162_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-020-05842-9","volume":"184","author":"W Gao","year":"2020","unstructured":"Gao\u00a0W, Zeng\u00a0Y, Fei\u00a0X, Chen\u00a0X, Shen\u00a0K. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a\u00a0multi-institutional retrospective analysis. Breast Cancer Res Treat. 2020;184:193\u2013202.","journal-title":"Breast Cancer Res Treat"},{"key":"2162_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-011-1565-4","volume":"128","author":"T Vandorpe","year":"2011","unstructured":"Vandorpe\u00a0T, Smeets\u00a0A, Van Calster\u00a0B, Van Hoorde\u00a0K, Leunen\u00a0K, Amant\u00a0F, et al. Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a\u00a0cross-sectional study on 4,292\u00a0consecutive patients. Breast Cancer Res Treat. 2011;128:429\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"2162_CR32","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2022. www.r-project.org."},{"key":"2162_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s12282-013-0489-8","volume":"22","author":"B Zengel","year":"2015","unstructured":"Zengel\u00a0B, Yararbas\u00a0U, Duran\u00a0A, Uslu\u00a0A, Eliyatkin\u00a0N, Demirkiran\u00a0MA, et\u00a0al. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast. Breast Cancer. 2015;22:374\u201381.","journal-title":"Breast Cancer"},{"key":"2162_CR34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/00000658-199522240-00012","volume":"222","author":"TJ Yeatman","year":"1995","unstructured":"Yeatman\u00a0TJ, Cantor\u00a0AB, Smith\u00a0TJ, Smith\u00a0SK, Reintgen\u00a0DS, Miller\u00a0MS, et\u00a0al. Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg. 1995;222:549\u201359. discussion 59\u201361.","journal-title":"Ann Surg"},{"key":"2162_CR35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1072-7515(98)00051-9","volume":"186","author":"DJ Winchester","year":"1998","unstructured":"Winchester\u00a0DJ, Chang\u00a0HR, Graves\u00a0TA, Menck\u00a0HR, Bland\u00a0KI, Winchester\u00a0DP. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J\u00a0Am Coll Surg. 1998;186:416\u201322.","journal-title":"J Am Coll Surg"},{"key":"2162_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1477-7819-8-34","volume":"8","author":"JH Lee","year":"2010","unstructured":"Lee\u00a0JH, Park\u00a0S, Park\u00a0HS, Park\u00a0BW. Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a\u00a0case control study. World J Surg Oncol. 2010;8:34.","journal-title":"World J Surg Oncol"},{"key":"2162_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1023\/B:BREA.0000021038.97593.8b","volume":"85","author":"T Korhonen","year":"2004","unstructured":"Korhonen\u00a0T, Huhtala\u00a0H, Holli\u00a0K. A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat. 2004;85:23\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"2162_CR38","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","volume":"93","author":"CI Li","year":"2005","unstructured":"Li\u00a0CI, Uribe\u00a0DJ, Daling\u00a0JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93:1046\u201352.","journal-title":"Br J Cancer"},{"key":"2162_CR39","first-page":"43","volume":"68","author":"P Casolo","year":"1997","unstructured":"Casolo\u00a0P, Raspadori\u00a0A, Drei\u00a0B, Amuso\u00a0D, Mosca\u00a0D, Amorotti\u00a0C, et\u00a0al. Natural history of breast cancer: lobular carcinoma versus ductal carcinoma in our experience. Ann Ital Chir. 1997;68:43\u20137. discussion 8.","journal-title":"Ann Ital Chir"},{"key":"2162_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/cncr.20054","volume":"100","author":"JM Classe","year":"2004","unstructured":"Classe\u00a0JM, Loussouarn\u00a0D, Campion\u00a0L, Fiche\u00a0M, Curtet\u00a0C, Dravet\u00a0F, et\u00a0al. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a\u00a0prospective study. Cancer. 2004;100:935\u201341.","journal-title":"Cancer"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02162-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T11:09:18Z","timestamp":1694516958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02162-y"}},"subtitle":["Analysis of the Clinical Tumor Register of the AGO Austria"],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":40,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02162-y","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"27 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Danzinger, K.\u00a0P\u00f6ckl, G.\u00a0Kronawetter, C.\u00a0Pfeifer, S.\u00a0Behrendt, P.\u00a0Gscheidlinger, L.\u00a0Harrasser, H.\u00a0M\u00fchlb\u00f6ck, W.\u00a0Dirschlmayer, C.\u00a0Schauer, R.\u00a0Reitsamer, H.\u00a0Uher, K.\u00a0Sch\u00f6nau, I.\u00a0Delmarko and C.F.\u00a0Singer declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the Medical University of Vienna. All procedures performed in our study were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. According to the ethics committee of the Medical University of Vienna, written informed consent was not required owing to the retrospective design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}